@article{a20acb3d6f4446d5bb25036856fd952b,
title = "Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML",
author = "H. Wu and C. Hu and A. Wang and Weisberg, {E. L.} and W. Wang and C. Chen and Z. Zhao and K. Yu and J. Liu and J. Wu and A. Nonami and L. Wang and B. Wang and Stone, {R. M.} and S. Liu and Griffin, {J. D.} and J. Liu and Q. Liu",
note = "Funding Information: JL, QL and WW are supported by the grant of {\textquoteleft}Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation (2014-2016){\textquoteright} from Chinese Academy of Sciences. ZZ is supported by Anhui Province Natural Science Foundation Annual Key Program (grant number: 1301023011). We thank China {\textquoteleft}Thousand Talents Program{\textquoteright} support for QL and {\textquoteleft}Hundred Talents Program{\textquoteright} of The Chinese Academy of Sciences support for JL and WW.",
year = "2016",
month = mar,
day = "1",
doi = "10.1038/leu.2015.175",
language = "English",
volume = "30",
pages = "754--757",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "3",
}
